Lantheus Holdings, Inc. Long-Term Debt, Maturity, Remainder of Fiscal Year
Lantheus Holdings, Inc. (LNTH) had Long-Term Debt, Maturity, Remainder of Fiscal Year of $0 as of 2024-06-30, per its 10-Q filed 2024-07-31.
Discontinued › Notes › Commitment and Contingencies
us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear · last filed 2024-07-31
- 2024-06-30: Long-Term Debt, Maturity, Remainder of Fiscal Year $0.00.
- 2024-03-31: Long-Term Debt, Maturity, Remainder of Fiscal Year $0.00.
- 2023-09-30: Long-Term Debt, Maturity, Remainder of Fiscal Year $0.00.
- 2023-06-30: Long-Term Debt, Maturity, Remainder of Fiscal Year $0.00.
| Period end | Long-Term Debt, Maturity, Remainder of Fiscal Year |
|---|---|
| 2024-06-30 | $0.00 10-Q · filed 2024-07-31 |
| 2024-03-31 | $0.00 10-Q · filed 2024-05-02 |
| 2023-09-30 | $0.00 10-Q · filed 2023-11-02 |
| 2023-06-30 | $0.00 10-Q · filed 2023-08-03 |
| 2023-03-31 | $0.00 10-Q · filed 2023-05-04 |
| 2022-09-30 | $3.75M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $6.25M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $8.75M 10-Q · filed 2022-04-29 |
| 2021-09-30 | $2.50M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $5.00M 10-Q · filed 2021-07-28 |
| 2021-03-31 | $7.50M 10-Q · filed 2021-05-04 |
| 2020-09-30 | $4.33M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $8.61M 10-Q · filed 2020-07-31 |
| 2020-03-31 | $7.50M 10-Q · filed 2020-04-30 |
| 2019-09-30 | $2.50M 10-Q · filed 2019-10-31 |
| 2019-06-30 | $5.00M 10-Q · filed 2019-07-25 |
| 2019-03-31 | $2.06M 10-Q · filed 2019-04-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B |